Simple jQuery Dropdowns

Browsing by Author Johnny Mahlangu

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
1-Jan-2012Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: A randomized controlled trialErich V. de Paula; Kaan Kavakli; Johnny Mahlangu; Yasmin Ayob; Steven R. Lentz; Massimo Morfini; László Nemes; Silva Z. Šalek; Midori Shima; Jerzy Windyga; Silke Ehrenforth; Ampaiwan Chuansumrit; Universidade Estadual de Campinas; Ege University Medical School; Academic Hospital; National Blood Center; University of Iowa; Azienda Ospedaliera Careggi; National Hemophilia Center; University of Zagreb School of Medicine; Nara Kenritsu Ika Daigaku Fozuku Byoin; Institute of Haematology and Transfusion Medicine, Warsaw; Novo Nordisk AS; Mahidol University
18-Dec-2014Recombinant long-acting glycoPEGylated factor IX in hemophilia B: A multinational randomized phase 3 trialPeter W. Collins; Guy Young; Karin Knobe; Faraizah Abdul Karim; Pantep Angchaisuksiri; Claus Banner; Türkiz Gürsel; Johnny Mahlangu; Tadashi Matsushita; Eveline P. Mauser-Bunschoten; Johannes Oldenburg; Christopher E. Walsh; Claude Negrier; Cardiff University; Keck School of Medicine of USC; Novo Nordisk AS; National Blood Centre; Mahidol University; Gazi University, Faculty of Medicine; University of Witwatersrand; Nagoya University Hospital; Van Creveld Haemophilia Clinic; Universitats-Klinikum Bonn und Medizinische Fakultat; The Mount Sinai Medical Center; Universite Claude Bernard Lyon 1